MAPT and Parkinson disease: To date, only one study focused on plasma p-tau231 as a biomarker to discriminate between PD and HC [29], but no study investigated this or other tau species in plasma or serum in parkinsonian syndromes, highlighting the need for further work in this largely unexplored field.